Rickettsia monoclonal antibody

ViroStat has released a new monoclonal antibody to the rickettsiae LPS. It is reactive with all members of the spotted fever group of rickettsiae. It does not cross react with the typhus group (R. typhi or R. prowazekii). This new antibody functions in enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assay (IFA) and may also function in other rapid test formats.

Rickettsia rickettsii is an obligate intracellular Gram-negative bacterium that can infect humans and other invertebrates. The most common human disease is spotted fever. Transmission occurs from the bite of various infected arthropods, the most common being the American dog tick and the Rocky Mountain wood tick. Typical symptoms are fever, headache and a rash. Prompt treatment with doxycycline is recommended.

www.virostat-inc.com

 

Other news

Upcoming Events

Challenges in the clinical biochemistry laboratory and beyond

The Royal College of Pathologists
28 February 2019

British Society for Haematology 59th Annual Scientific Meeting

SEC Glasgow
1-3 April 2019

Focus 2019

SEC Glasgow
1-3 May 2019

Respiratory Microbiology - A Day of Inspiration

Royal Air Force Museum, Hendon
16 May 2019

Clinical and Laboratory Haemostasis 2019

The Atrium Conference Centre, Sheffield Hallam University
5-6 June 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Feb 2019

Early disease detection: a collaborative approach

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.